PHEODOL Trademark

Trademark Overview


On Friday, February 25, 2011, a trademark application was filed for PHEODOL with the United States Patent and Trademark Office. The USPTO has given the PHEODOL trademark a serial number of 85251681. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 21, 2018. This trademark is owned by GOLDEN BIOTECHNOLOGY CORPORATION. The PHEODOL trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional addit...
pheodol

General Information


Serial Number85251681
Word MarkPHEODOL
Filing DateFriday, February 25, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 21, 2018
Registration Number4100185
Registration DateTuesday, February 14, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2011

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAdjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 21, 2018
Primary Code005
First Use Anywhere DateFriday, February 25, 2011
First Use In Commerce DateTuesday, July 19, 2011

Trademark Owner History


Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTaipei County 2514
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei County 2514
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei County 2514
TW

Trademark Events


Event DateEvent Description
Friday, September 21, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, February 14, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 14, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, January 10, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 9, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, January 4, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, December 31, 2011STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 8, 2011USE AMENDMENT FILED
Friday, December 30, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 8, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, September 13, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2011PUBLISHED FOR OPPOSITION
Thursday, June 16, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 16, 2011ASSIGNED TO LIE
Thursday, June 2, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 24, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 24, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 24, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 7, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 7, 2011NON-FINAL ACTION E-MAILED
Thursday, April 7, 2011NON-FINAL ACTION WRITTEN
Wednesday, April 6, 2011ASSIGNED TO EXAMINER
Wednesday, March 2, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 1, 2011NEW APPLICATION ENTERED IN TRAM